— Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected.
— Total sales grew 8.8% to $4.13 billion vs. expected $4.11 billion. Organic sale grew 8% in Q4. Orthopaedics sales increased 6.7% year-over-year to $1.5 billion.
— Adjusted EPS is estimated to be in the range of $9.00 to $9.20 for 2020 and in the range of $2.05 and $2.10 for 1Q20.
— 2020 organic net sales growth expected to be 6.5% to 7.5%.
— SYK shares traded flat in the after-hours trading session.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
